Publications by authors named "Eric Guenzi"

Claim this Profile
comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira or undergoing repeated switches between Humira and AVT02.
Kathleen Richter, Halimu N Haliduola, Jana Schockaert, Aurélie Mazy, Nataliya Reznichenko, Eric Guenzi

Immunother Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults.
Christopher Wynne, Christian Schwabe, Heimo Stroissnig, Roshan Dias, Joanna Sobierska, Eric Guenzi

Expert Opin Biol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe.
Nemanja Damjanov, Nana Kirvalidze, Nana Kurashvili, Fausto Berti, Matjaz Steiger, Eric Guenzi

Expert Opin Biol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint analysis of PK and immunogenicity outcomes using factorization model - a powerful approach for PK similarity study.
Halimu N Haliduola, Fausto Berti, Heimo Stroissnig, Eric Guenzi, Hendrik Otto

BMC Med Res Methodol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST).
Christopher Wynne, Christian Schwabe, Charlotte Lemech, Heimo Stroissnig, Roshan Dias, Eric Guenzi

Expert Opin Investig Drugs· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study.
Steven R Feldman, Nataliya Reznichenko, Grazyna Pulka, Külli Kingo, George Galdava, Eric Guenzi

BioDrugs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration.
Yun Dong, Roman Fischer, Petrus J W Naudé, Olaf Maier, Csaba Nyakas, Eric Guenzi

Proc Natl Acad Sci U S A· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity.
Fabian Richter, Timo Liebig, Eric Guenzi, Andreas Herrmann, Peter Scheurich

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.
Jing Hua, Nikolai Gross, Brita Schulze, Uwe Michaelis, Hermann Bohnenkamp, Eric Guenzi

Mol Vis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats.
Susanne Herber-Jonat, Rashmi Mittal, Stefan Gsinn, Hermann Bohnenkamp, Eric Guenzi

Inflamm Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.
Martin E Eichhorn, Ivan Ischenko, Siiri Luedemann, Sebastian Strieth, Armine Papyan, Eric Guenzi

Int J Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal HIV type 1 infection suppresses MMP-1 expression in endothelial cells of uninfected newborns: nonviral vertical transmission of HIV type 1-related effects.
Anita Jörg, Thomas Grubert, Thomas Grimm, Eric Guenzi, Elisabeth Naschberger

AIDS Res Hum Retroviruses· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
Thomas Grimm, Sabine Schneider, Elisabeth Naschberger, Jürgen Huber, Eric Guenzi

Blood· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells.
Elisabeth Naschberger, Thomas Werner, Ana B Vicente, Eric Guenzi, Kristin Töpolt

Biochem J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression.
Eric Guenzi, Kristin Töpolt, Clara Lubeseder-Martellato, Anita Jörg, Elisabeth Naschberger

EMBO J· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases.
Clara Lubeseder-Martellato, Eric Guenzi, Anita Jörg, Kristin Töpolt, Elisabeth Naschberger

Am J Pathol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis